Where the evidence is already solid Beyond diabetes and obesity, GLP-1 drugs have now earned regulatory approval in several new areas
The result is durable but not permanent
Declaration of Interest Sunovion Pharmaceuticals Inc., provided funding for this research
Short-term use of medications like prochlorperazine or ondansetron can provide relief while your body adjusts to the medication or during dose increases
Br J Pharmacol 178:33273341 Aleksandrov DA, Zagryagskaya AN, Pushkareva MA, Bachschmid M, Peters-Golden M, Werz O, Sudina GF (2006) Inhibition of 5-lipoxygenase activation in polymorphonuclear leukocytes and MonoMac6 cells by cholesterol and its anionic derivatives
Association between VDR and CYP24A1 polymorphisms, atopic dermatitis, and biochemical lipid and vitamin D profiles in Spanish population: case-control study